Dec 24 (Reuters) - Shares of Agios Pharmaceuticals (AGIO) jumped 18% on Wednesday after the U.S. Food and Drug Administration approved the expanded use of its drug for the treatment of a type of blood disorder.
The drug mitapivat is now approved as a treatment for patients with anemia in both non-transfusion-dependent and transfusion-dependent alpha- or beta-thalassemia, the company said late on Tuesday.
Thalassemia is an inherited blood disorder affecting the body's ability to produce hemoglobin and healthy red blood cells.
The drug, under the brand name Aqvesme, is expected to be available in late January next year, following the implementation of the required safety program.
Mitapivat was already approved by the U.S. FDA in 2022 to treat low red blood cell counts in adults with pyruvate kinase deficiency, under the brand name of Pyrukynd.
"The approval unlocks an additional $320 million in peak revenue opportunity layered atop the existing mitapivat franchise," Truist analyst Gregory Renza said.
The latest approval is based on a late-stage study in which patients receiving mitapivat showed a statistically significant increase in hemoglobin response compared to those on placebo.
Aqvesme will carry a boxed warning for liver function tests every four weeks during the first 24 weeks of treatment and advises against use in patients with cirrhosis, Renza added.
(Reporting by Siddhi Mahatole in Bengaluru; Editing by Vijay Kishore)
LATEST POSTS
- 1
Medicine doesn’t just have ‘conscientious objectors’ − there are ‘conscientious providers,’ too - 2Figure out How to Augment Your Rooftop Substitution Speculation
- 3‘Slender Man’ attacker back in custody. What we know about Morgan Geyser's disappearance and what happens next.
- 4Audits of 6 American Busssiness Class Flights
- 5NASA troubleshoots Artemis II toilet problem in otherwise smooth flight
- Step by step instructions to Show Children the Significance of Appropriate Handshaking
- Spotify Wrapped and Apple Music Replay are here: Top songs, albums and artists of 2025
- Craig the beer-ambassador elephant dies aged 54
- How to watch Dick Clark’s New Year’s Rockin’ Eve with Ryan Seacrest: Start time, TV channel, performers and more
- OPEC’s No. 2 Producer Burns Its Own Gas—Then Buys Iran’s
- Big Bear glows with big stars | Space photo of the day for Dec. 31, 2025
- Figure out How to Explore the Infotainment Framework in the Slam 1500.
- Six Flags Opens the Tallest, Fastest and Longest Roller Coaster in the World
- Get To Be familiar with The Historical backdrop Of Western Medication
